Craneware (CRW) Given “Buy” Rating at Peel Hunt

Peel Hunt restated their buy rating on shares of Craneware (LON:CRW) in a report published on Friday.

Craneware stock traded up GBX 170 ($2.22) on Friday, hitting GBX 3,270 ($42.73). 122,015 shares of the stock traded hands, compared to its average volume of 14,260. Craneware has a 1 year low of GBX 1,170 ($15.29) and a 1 year high of GBX 2,040 ($26.66).

The company also recently disclosed a dividend, which will be paid on Thursday, December 6th. Shareholders of record on Thursday, November 8th will be given a dividend of GBX 14 ($0.18) per share. The ex-dividend date of this dividend is Thursday, November 8th. This represents a yield of 0.52%. This is a positive change from Craneware’s previous dividend of $10.00.

In other news, insider Keith Neilson acquired 4,848 shares of the stock in a transaction on Friday, September 7th. The stock was acquired at an average price of GBX 3,082 ($40.27) per share, with a total value of £149,415.36 ($195,237.63).

Craneware Company Profile

Craneware plc engages in the development, licensing, and ongoing support of computer software for the United States healthcare industry. The company offers patient engagement solutions that enhance patient satisfaction with billing by providing accurate out-of-pocket estimates and mobile-friendly payment plans; reduce bad debt and ineffective paper collections with upfront patient engagement and point-of-service collections; and provide all-payor medical necessity validation and prior authorization coverage to ensure accuracy and prevent denials.

See Also: How Investors Use a Balance Sheet

Receive News & Ratings for Craneware Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Craneware and related companies with's FREE daily email newsletter.

Leave a Reply